Your healthcare provider can help differentiate between a typical sunburn, increased UV vulnerability due to Wegovy-related changes, or a true drug-induced photosensitivity reaction requiring specific intervention
New Technology, Trusted Standards The incredible service you expect from Kohll's is at the core of what we do here at Preventative Medical Clinic
NICE guidance (NG28) recommends GLP-1 receptor agonists as a treatment option for adults with type 2 diabetes when: Triple therapy with metformin and two other oral drugs is not effective, not tolerated or contraindicated The person has a BMI of 35 kg/m or higher (adjust accordingly for people from particular ethnic groups) and specific psychological or other medical problems associated with obesity The person has a BMI lower than 35 kg/m and insulin would have significant occupational implications, or weight loss would benefit other significant obesity-related comorbidities GLP-1 receptor agonists may also be considered in combination with insulin therapy in specialist care settings Beyond glycaemic control, specific GLP-1 receptor agonists offer significant cardiovascular benefits
P., Papanas, N., Prazny, M., Rizvi, A
